Insider Trading26 Jun 2026, 01:58 pm
Gland Pharma Closes Trading Window for Q2 2026 Results
AI Summary
Gland Pharma Ltd has announced the closure of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from Saturday, June 27, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. The specific date for the board meeting to approve these results will be communicated later. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.
Key Highlights
- Trading window closed effective June 27, 2026.
- Closure is for unaudited financial results of Q2 2026.
- Window reopens 48 hours post-results declaration.
- Aims to comply with SEBI Insider Trading Regulations.
- Board meeting date for results approval to be announced.
Price Impact
More from GLAND